Quinazoline derivatives and their use in the treatment of thrombocythemia

Details for Australian Patent Application No. 2005271274 (hide)

Owner Shire Holdings AG

Inventors Franklin, Richard

Agent Mallesons

Pub. Number AU-B-2005271274

PCT Pub. Number WO2006/017822

Priority 60/598,437 04.08.04 US

Filing date 4 August 2005

Wipo publication date 16 February 2006

Acceptance publication date 4 March 2010

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 239/84 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/017822 Priority application(s): WO2006/017822

4 March 2010 Application Accepted

  Published as AU-B-2005271274

15 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005271275-Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors

2005271264-Method for measuring dynamics of selfassembling systems of biological molecules in vivo and uses for discovering or evaluating therapeutic agents